en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
 
4/2022
vol. 124
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
Opis przypadku

Torpedo maculopathy – a case series presentation

Joanna Mamczur
1
,
Marta Pawlak
1
,
Anna Gotz-Więckowska
1

1.
Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2022, 124 , 4: 239-244
Data publikacji online: 2022/12/19
Plik artykułu:
- KO-00371_EN.pdf  [1.06 MB]
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Metryki PlumX:
 

INTRODUCTION

Torpedo maculopathy is a congenital, nonprogressive lesion of the retinal pigment epithelium (RPE) and/or choroid [1]. It was first described by Roseman and Gass in 1992 [2]. In most cases it is asymptomatic and is found accidentally [3]. The lesion is usually unilateral and is located in the temporal region of the macula. The diagnosis of torpedo maculopathy is clinical, because its location and “torpedo-like” shape are unique. Additional imaging tests such as optical coherence tomography (OCT) and fundus autofluorescence (FAF) are useful in differential diagnosis [4]. We aim to present a case series of four patients, in whom a “torpedo-like” lesion was found in the ophthalmic investigation. All fundus images (except Figure 4) and OCT, included in this article, have been obtained with DRI OCT Trition. The FAF and fundus images in Figure 4 were captured with a Zeiss Clarus 700. FAF images in Figures 2, 6 and 8 were acquired with a mydriatic retinal camera: the Topcon TRC-50DX.

CASE REPORTS

Case 1
An 8-year-old boy was referred to the clinic for an opinion regarding a retinal lesion in his left eye that was found during a routine ophthalmic check-up. On the examination his best corrected visual acuity (BCVA) was 1.0 in both eyes. The Amsler grid test was negative in both eyes. Dilated fundus examination revealed in the left eye a “torpedo-like” hypopigmented lesion located in the temporal region of the macula with the tip pointing towards the foveola (Figure 1). We did not find any other abnormalities. OCT and FAF of the left eye were performed. OCT showed thickening of the RPE layer located in the area of the “torpedo-like” lesion (Figure 1). FAF revealed variable autofluorescence of the area corresponding to the lesion (Figure 2).
Case 2
An 11-year-old girl was referred to the clinic because of a retinal lesion of the right eye that was found on a routine check-up. She was asymptomatic. Her BCVA was 1.0 in both eyes. Fundus imaging of the right eye revealed an oval, hypopigmented lesion located in the temporal region of the macula, adjacent to the fovea (Figures 3 and 4). It is important to note that the fundus image in Figure 4. is of the same patient as in Figure 3 but was obtained with a different retinal camera (Figure 3 with DRI OCT Triton, Figure 4 with Zeiss Clarus 700). In OCT we observed outer retinal cavitation and thickening of the RPE layer temporarily to the fovea (Figure 3). FAF showed hypoautofluorescence of the lesion and a temporarily located hyperautofluorescent spot (Figure 4).
Case 3
A boy born at 35 weeks of gestation was first referred to the ophthalmic department for ocular consultation at the age of 17 months. He suffered from microcephaly and psychomotor retardation. He had a normal karyotype and negative tests for SMN1 gene, toxoplasmosis, Epstein-Barr virus, cytomegalovirus and common metabolic disorders. On the examination we observed, in the left eye, a hypopigmented lesion with well-defined margins located in the temporal region of the macula. At the age of 4 years his BCVA was 0.5 in the left eye and 0.6 in the right eye. The OCT showed a subtle elevation of the ellipsoid zone in the temporal region of the macula (Figure 5). FAF revealed an isoautofluorescent lesion surrounded by a hypoautofluorescent region (Figure 6).
Case 4
A 17-year-old female patient visited our clinic for further examinations with the initial diagnosis of retinal inflammation in the left eye. Her chief complaints were “wavy vision” and headache appearing in the evenings. Her past ocular history was unremarkable. Two weeks before the visit she had a traffic accident. Her BCVA was 1.0 in both eyes. The Amsler grid test was negative for the right eye, but when looking with the left eye, she reported seeing narrowing of the lines and grids located at the left part of the chart. On the left eye fundus examination we observed a hypopigmented lesion of the RPE in the center of the macula. Its border was hyperpigmented. The test for toxoplasmosis was negative. We performed OCT and fundus imaging (Figure 7). FAF showed variable autofluorescence of the lesion (Figure 8). Retinal inflammation was excluded and torpedo maculopathy was diagnosed. The patient has observed for the next years (2017-2020); the metamorphopsia disappeared, while OCT findings remained unchanged.

DISCUSSION

Classically, torpedo maculopathy is described as an asymptomatic, solitary, hypopigmented lesion of the RPE, located in the temporal region of the macula [4, 5]. It is horizontally oval. The nasal margin ends with a sharp tip that points into the foveola and/or optic disc [4, 6]. The temporal margin is rounded or like a hyperpigmented “frayed tail” [4]. The lesion, in shape, resembles a torpedo (an underwater missile) or a teardrop [1]. The pathogenesis of torpedo maculopathy is unclear. There are some theories that have been proposed: congenital defects in the development of the nerve fiber layer, abnormal development of choroidal or ciliary vasculature or persistent defect in the development of the RPE in the fetal temporal bulge [4, 6–8]. There have been noted correlations that support a congenital retinal nerve fiber layer-driven etiology, namely: most of the lesions points toward the optic nerve; lesion horizontal angularity is consistent with distribution of the horizontal raphe of the retinal nerve fiber layer; and the nasal margin localizes at the junction of the superior arcuate, inferior arcuate and papillomacular bundles of the retinal fiber layer. Moreover, it has been observed, based on retinal laser ellipsometry, that the nasal well-shaped margin of the lesion is associated with relatively low density of nerve fiber layer. This aspect may explain the consistent localization of torpedo maculopathy [6]. Analysis of the literature proves that the manifestation of torpedo maculopathy is diverse. There have been reported cases in which two “torpedo-like” lesions were present in one eye or the main lesion was accompanied by satellite lesions [3, 9]. Location of the lesion also varies. It has been found outside the macula (in the temporal region of the retina, inferior to the macula, inferonasal to the optic disc) or in its center [3, 10–12]. However, some characteristics, in most cases, remained unchanged, i.e.: an oval, torpedo-like shape and a sharp tip pointing towards the foveola [4, 10]. Standard automated perimetry may reveal the presence of a scotoma corresponding to the location of the lesion, but in some cases, a scotoma can only be detected in microperimetry [13]. Cases of torpedo maculopathy that coexisted with retinoblastoma have also been described [5]. Although the diagnosis of torpedo maculopathy is made clinically, OCT and FAF may be helpful to support the diagnosis and exclude other disorders. Based on OCT images, four types of lesions have been identified [1, 14, 15]. In 2015 Wong et al. classified lesions, in patients with torpedo maculopathy, into two types: type 1 – lesion with attenuation of outer retinal structures but without presence of outer retinal cavitation; and type 2 – lesion with both attenuation and cavitations of outer retinal structures [14]. In 2018 Tripathy et al. introduced a new, third type: degeneration of the outer retina accompanied with excavation of the inner retina and choroid [15]. The fourth type was described in 2020 by Light et al. and it represents a lesion with a preserved ellipsoid zone, lack of subretinal fluid, but with inner choroidal excavation [1]. FAF usually shows uniform or variable hypoautofluorescence at the area of the lesion and small regions of hyperautofluorescence at its margins [12, 14]. Usually torpedo maculopathy is asymptomatic, non-progressive and does not require any treatment [4]. However, the risk of choroidal neovascular membrane formation is an important consideration for long-term follow-up [5]. In all of our patients, we have identified unilateral, torpedo-like lesions. In three cases the lesion was located in the left eye. Three of them did not involve a fovea and were asymptomatic. However, in case 4 the lesion was located in the fovea, which resulted in distorted vision. According to the OCT classification, we can classify our patients into type 1 (cases 1 and 3) and type 2 (cases 2 and 4). None of our patients had type 3 or 4 lesions. FAF has been performed in all cases (Figures 2, 4, 6 and 8). In cases 1 and 4 it revealed variable autofluorescence of the lesion. In case 2 the lesion was hypoautofluorescent and there was a hyperautofluorescent spot located temporarily to the macula. In case 3, an isoautofluorescent lesion was surrounded by a region of hypoautofluorescence. Patients have not been provided with any treatment. However, we recommended a yearly follow-up. Torpedo maculopathy should be distinguished from other retinal disorders, congenital and acquired. The differential diagnosis includes congenital toxoplasmosis, congenital hypertrophy of RPE, Turcot syndrome, Gardner syndrome, congenital simple hamartoma of the retina, choroidal nevus, and congenital Zika virus infection [6, 13]the underlying etiology of torpedo maculopathy has remained elusive. In this literature review, we provide new evidence to better support, reject and unify claims regarding cause, diagnosis, and proper clinical management of this disease. We reviewed 44 case reports and case series, which included 77 patients (after exclusions. Congenital toxoplasmosis manifests as retinochoroidal lesions. Active lesions appear as whitish foci, which after healing turn into scars [16]. It can be challenging to distinguish between torpedo maculopathy and toxoplasmosis on fundus examination. To exclude or confirm ocular toxoplasmosis one should perform serologic tests [17]. Congenital hypertrophy of the RPE (CHRPE) is a pigmented, flat, round or oval lesion that can be found at the mid-periphery or at the posterior pole. There are regions of RPE loss in the lesion area, which appear as depigmented lacunae. In OCT the region that underlies the lesion appears as loss of photoreceptors and outer retinal layers [18]. Fundus autofluorescence shows hypoautofluorescence with lacunae being isoautofluorescent or hypoautofluorescent [19]. Fluorescein angiography shows choroidal masking. Also, CHRPE can be a specific and sensitive marker of adenomatous polyposis of the colon (APC) or familial adenomatous polyposis (FAP) [18]. The lesions found in patients with FAP or APC resemble CHRPE but they are multifocal (more than three), bilateral, mixed (pigmented and depigmented), variable in shape (ovoid, pisciform, irregular, surrounded by depigmented halo), size (from dot-like to multiple disc diameters) and location (midperiphery, near the optic disc or macula) [18, 20-22]. Traboulsi and colleagues termed these lesions associated with polyposis syndrome as pigmented ocular fundus lesions (POFLs) [21, 23]. FAP may be present in Gardner and Turcot syndromes. Turcot syndrome is characterized by the coexistence of a primary central nervous system tumor (usually medulloblastoma or glioblastoma multiforme), numerous adenomatous colorectal polyps (APC) and colonic adenocarcinoma [24]. Gardner syndrome is an autosomal dominant subtype of FAP. It is characterized by adenomatous intestinal polyps, multiple osteomas in the skull, maxillae, mandible and cutaneous and subcutaneous masses [22, 25]. A congenital simple hamartoma of the retina (CSHRPE) is a rare, black, benign tumor; it is located in a macula adjacent to the fovea. It penetrates through all layers of the retina, may protrude into the vitreous and is usually accompanied by a feeder arteriole and venule [18, 20]. Sometimes, the lesion is complicated with retinal traction or intraretinal hemorrhages, which decreases visual acuity. OCT shows elevation of the inner retina and marked optical shadowing at the level of the outer retina and choroid, with normal retina adjacent to the lesion [18]. Choroidal nevus is round or oval and its color is yellowish to brown. In a chronic lesion OCT shows the adjacent RPE to be atrophic, hypertrophic or metaplastic and to be accompanied with drusen [20]. Congenital Zika virus is associated with microcephaly and may affect the posterior segment of the eye. The ocular manifestations that have been reported include macular chorioretinal atrophy, RPE mottling, optic nerve hypoplasia, atrophy, pallor and increased cup-to-disc ratio. Most of the findings occurred bilaterally [26-29]. None of our patients suffered from any systemic or genetic disease. All of them had a hypopigmented, unilateral lesion. In patients 3 and 4 we excluded toxoplasmosis infection. In patients 1 and 2 the temporal location and torpedo-like shape of the lesion enabled us to make a clinical diagnosis.

CONCLUSIONS

We present four patients diagnosed with torpedo maculopathy. In all patients the lesion was unilateral. All patients had attenuation of outer retinal layers on OCT. In most cases the diagnosis of torpedo maculopathy can be made clinically. Additional imaging tests such as OCT and FAF are sometimes helpful in differential diagnosis. In the long-term follow-up it is important to consider the risk of choroidal neovascular membrane formation.

DISCLOSURE

The authors declare no conflicts of interest.

References

1. Light JG, Alvin Liu TY. A novel phenotype of torpedo maculopathy on spectral-domain optical coherence tomography. Am J Ophthalmol Case Rep 2020; 20: 100956.
2. Roseman RL, Gass JD. Solitary hypopigmented nevus of the retinal pigment epithelium in the macula. Arch Ophthalmol 1992; 110: 1358-1359. doi: 10.1001/archopht.1992.01080220020005. [published erratum appears in: Arch Ophthalmol 1992; 110: 1762].
3. Singh S, Muralidhar NS, Murthy H. Torpedo Maculopathy with Satellite Lesion. DJO 2020; 31: 90-92.
4. Shields CL, Guzman JM, Shapiro MJ, et al. Torpedo Maculopathy at the Site of the Fetal “Bulge”. Arch Ophthalmol 2010; 128: 499-501.
5. Shirley K, O’Neill M, Gamble R, et al. Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population. Eye 2018; 32: 1315-1320.
6. Williams PJ, Salek S, Prinzi RA, et al. Distribution patterns of torpedo maculopathy: Further evidence of a congenital retinal nerve fiber layer-driven etiology. Saudi J Ophthalmol 2019; 33: 260-267.
7. Teitelbaum BE, Hachey DL, Messner LV. Torpedo maculopathy. J Am Optom Assoc 1997; 68: 373-376.
8. Pian D, Ferruci S, Anderson SF, et al. Paramacular coloboma. Optom Vis Sci 2003; 80: 556-563.
9. Raju B, Nooyi C, Raju ND, et al. Torpedo maculopathy with double torpedoes. Indian J Ophthalmol 2018; 66: 1189-1190.
10. Venkatesh R, Jain K, Pereira A, et al. Torpedo Retinopathy. J Ophthalmic Vis Res 2020; 15: 187-194.
11. Smith MJ, Sia DIT, Greve M. Torpedo maculopathy – inferior variant. Can J Ophthalmol 2021; Mar 18: S0008-4182(21)00045-4.
12. Jain S, Kumawat D, Kumar V. Multimodal imaging of torpedo-shaped fundus lesions: New insights. Indian J Ophthalmol 2018; 66: 1211-1213.
13. Trevino R, Kiani S, Raveendranathan P. The Expanding Clinical Spectrum of Torpedo Maculopathy. Optom Vis Sci 2014; 91 (4 Suppl 1): S71-78.
14. Wong EN, Fraser-Bell S, Hunyor AP, et al. Novel optical coherence tomography classification of torpedo maculopathy. Clin Exp Ophthalmol 2015; 43: 342-348.
15. Tripathy K, Sarma B, Mazumdar S. Commentary: Inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography. Indian J Ophthalmol 2018; 66: 1213-1214.
16. Park YH, Nam HW. Clinical Features and Treatment of Ocular Toxoplasmosis. Korean J Parasitol. 2013; 51: 393-399.
17. Feliciano-Alfonso JE, Vargas-Villanueva A, Marin MA, et al. Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol. Syst Rev 2019; 8: 146.
18. Biswas S. Congenital pigmentary and vascular abnormalities of the retina. In: Taylor and Hoyt’s Pediatric Ophthalmology and Strabismus. 5th ed. Elsevier Inc. 2016; 516-524.
19. Fung AT, Pellegrini M, Shields CL. Congenital Hypertrophy of the Retinal Pigment Epithelium: enhanced-depth imaging optical coherence tomography in 18 cases. Ophthalmology 2014; 121: 251-256.
20. Freund KB, Sarraf D, Mieler WF, et al. Oncology. In: Freund KB, Mieler WF, Sarraf D, et.al. Retinal atlas 2nd ed. Elsevier 14th November 2016; Chapter 8: 763-912.
21. Gorovoy IR, de Alba Campomanes A. A potential life-saving diagnosis – recognizing Turcot syndrome. J AAPOS 2014; 18: 186-188.
22. Villegas VM, Schwartz SG, Flynn HW, et al. Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 222-226.
23. Traboulsi EI, Apostolides J, Giardiello FM, et al. Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis. Ophthalmic Genet 1996; 17: 167-174.
24. Dipro S, Al-Otaibi F, Alzahrani A, et al. Turcot Syndrome: A Synchronous Clinical Presentation of Glioblastoma Multiforme and Adenocarcinoma of the Colon. Case Rep in Oncol Med 2012; 2012: 1-6.
25. Panjwani S, Bagewadi A, Keluskar V, et al. Gardner’s Syndrome. J Clin Imaging Sci 2011; 1: 65.
26. Yepez JB, Murati FA, Pettito M, et al. Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela. JAMA Ophthalmol 2017; 135: 440.
27. Miranda HA de, Costa MC, Frazão MAM, et al. Expanded Spectrum of Congenital Ocular Findings in Microcephaly with Presumed Zika Infection. Ophthalmology 2016; 123: 1788-1794.
28. Verçosa I, Carneiro P, Verçosa R, et al. The visual system in infants with microcephaly related to presumed congenital Zika syndrome. J AAPOS 2017; 21: 300-304.e1.
29. Guevara JG, Agarwal-Sinha S. Ocular abnormalities in congenital Zika syndrome: a case report, and review of the literature. J Med Case Reports 2018; 12: 161.
facebook linkedin twitter
© 2023 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.